Bristol-Myers' top selling blood thinner "Plavix" is going generic, reports CNBC's Seema Mody. Matt Cheslock, Virtu Financial, weighs in on how to trade the pharmaceuticals sector right now.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT